Sequoia China Leads Investment in Chinese Brain-Computer Interface Startup

Venture capital titan Sequoia China led a multimillion-dollar Angel funding round for brain-computer interface (BCI) startup Tianfukang Medical Technology Co. Ltd., signaling surging private capital confidence as Chinese neurotech developers shift from laboratory breakthroughs to commercial human trials. The investment, which included participation from the Yuanming Neuroscience Fund, marks the second major capital injection in six months for the one-year-old Beijing startup. Tianfukang previously secured early-stage backing from Fosun Pharma’s Fuxian Capital Star Venture Fund in March 2026. The capital expansion comes as China elevated brain-computer interface technology to a strategic priority in its 2026 national economic planning, designating neurotech…